Bortezomib (Velcade) With Standard Chemotherapy for Relapsed or Refractory Follicular Lymphoma

This study is ongoing, but not recruiting participants.

Study NCT00510887 Information provided by Duke University

First Received: August 1, 2007 Last Updated: May 28, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	June 2013
Estimated Primary Completion Date:	January 2012 (Final data collection date for primary outcome measure)